The DOI matches its Crossref record; 176 of the 176 references it cites were found in a registry or an index.
Regulatory T-cells in autoimmune diseases: Challenges, controversies and—yet—unanswered questions
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187 · cited 1×
“murine Tregs [11-13] and later, in humans, FOXP3 was shown to be expressed predominantly by the CD4 cells expressing the highest level of CD25 [14].”
BackgroundFoxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608 · cited 2×
“Subsequently, seminal studies performed by Sakaguchi and colleagues demonstrated that the 10% of CD4 T cells expressing CD25 were essential for the maintenance of self tolerance in mice [4-6].”
ResultIvanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Vignali, D. A. A., Collison, L. W., & Workman, C. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2343 · Cited by 3,463
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
Thornton, A. M., & Shevach, E. M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.287 · Cited by 2,639
Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S.-A., Wilkinson, J. E., Galas, D., Ziegler, S. F., & Ramsdell, F. (2001) · Nature Genetics · doi:10.1038/83784 · Cited by 2,636
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606
Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J.-F., Enjyoji, K., Linden, J., Oukka, M., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062512 · Cited by 2,470
FOXP3+ regulatory T cells in the human immune system
Sakaguchi, S., Miyara, M., Costantino, C. M., & Hafler, D. A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2785 · Cited by 2,439
Miyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Parizot, C., Taflin, C., Heike, T., Valeyre, D., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.019 · Cited by 2,291
CTLA-4 can function as a negative regulator of T cell activation
Walunas, T. L., Lenschow, D. J., Bakker, C. Y., Linsley, P. S., Freeman, G. J., Green, J. M., Thompson, C. B., & Bluestone, J. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90071-x · Cited by 2,222
The inhibitory cytokine IL-35 contributes to regulatory T-cell function
Collison, L. W., Workman, C. J., Kuo, T. T., Boyd, K., Wang, Y., Vignali, K. M., Cross, R., Sehy, D., Blumberg, R. S., & Vignali, D. A. A. (2007) · Nature · doi:10.1038/nature06306 · Cited by 2,066
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Trans-endocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4
Qureshi, O. S., Zheng, Y., Nakamura, K., Attridge, K., Manzotti, C., Schmidt, E. M., Baker, J., Jeffery, L. E., Kaur, S., Briggs, Z., et al. (2011) · Science · doi:10.1126/science.1202947 · Cited by 1,860
CD4+CD25high Regulatory Cells in Human Peripheral Blood
Baecher-Allan, C., Brown, J. A., Freeman, G. J., & Hafler, D. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.3.1245 · Cited by 1,859
Acosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A., & Sallusto, F. (2007) · Nature Immunology · doi:10.1038/ni1496 · Cited by 1,857 · cited 1×
“importance at environmental interfaces, such as the gut, skin and lungs [73-75].”
BackgroundLoss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis
Viglietta, V., Baecher-Allan, C., Weiner, H. L., & Hafler, D. A. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031579 · Cited by 1,856
Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L., & Powrie, F. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.7.995 · Cited by 1,615
Nakamura, K., Kitani, A., & Strober, W. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.5.629 · Cited by 1,594
Regulatory T Cell-Derived Interleukin-10 Limits Inflammation at Environmental Interfaces
Rubtsov, Y. P., Rasmussen, J. P., Chi, E. Y., Fontenot, J., Castelli, L., Ye, X., Treuting, P., Siewe, L., Roers, A., Henderson, W. R., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.02.017 · Cited by 1,586
Takahashi, T., Kuniyasu, Y., Toda, M., Sakaguchi, N., Itoh, M., Iwata, M., Shimizu, J., & Sakaguchi, S. (1998) · International Immunology · doi:10.1093/intimm/10.12.1969 · Cited by 1,568
Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M., Selby, W., Alexander, S. I., Nanan, R., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060468 · Cited by 1,512 · cited 1×
“In the CD4 pos CD25 high population, CD127 expression is inversely correlated with suppressive function [42-44].”
BackgroundLiyanage, U. K., Moore, T. T., Joo, H.-G., Tanaka, Y., Herrmann, V., Doherty, G., Drebin, J. A., Strasberg, S. M., Eberlein, T. J., Goedegebuure, P. S., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2756 · Cited by 1,467
Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.
Asano, M., Toda, M., Sakaguchi, N., & Sakaguchi, S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.387 · Cited by 1,330
Borsellino, G., Kleinewietfeld, M., Di Mitri, D., Sternjak, A., Diamantini, A., Giometto, R., Höpner, S., Centonze, D., Bernardi, G., Dell'Acqua, M. L., et al. (2007) · Blood · doi:10.1182/blood-2006-12-064527 · Cited by 1,286
Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy
Ehrenstein, M. R., Evans, J. G., Singh, A., Moore, S., Warnes, G., Isenberg, D. A., & Mauri, C. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040165 · Cited by 1,252
Induction and effector functions of TH17 cells
Bettelli, E., Korn, T., Oukka, M., & Kuchroo, V. K. (2008) · Nature · doi:10.1038/nature07036 · Cited by 1,216
Bates, G. J., Fox, S. B., Han, C., Leek, R. D., Garcia, J. F., Harris, A. L., & Banham, A. H. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.9584 · Cited by 1,200
Dieckmann, D., Plottner, H., Berchtold, S., Berger, T., & Schuler, G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.11.1303 · Cited by 1,139
Granzyme B and Perforin Are Important for Regulatory T Cell-Mediated Suppression of Tumor Clearance
Cao, X., Cai, S. F., Fehniger, T. A., Song, J., Collins, L. I., Piwnica-Worms, D. R., & Ley, T. J. (2007) · Immunity · doi:10.1016/j.immuni.2007.08.014 · Cited by 1,035
Human T Regulatory Cells Can Use the Perforin Pathway to Cause Autologous Target Cell Death
Grossman, W. J., Verbsky, J. W., Barchet, W., Colonna, M., Atkinson, J. P., & Ley, T. J. (2004) · Immunity · doi:10.1016/j.immuni.2004.09.002 · Cited by 1,020
Levings, M. K., Sangregorio, R., & Roncarolo, M.-G. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.11.1295 · Cited by 967
Gondek, D. C., Lu, L.-F., Quezada, S. A., Sakaguchi, S., & Noelle, R. J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.4.1783 · Cited by 942
Cell interactions in the induction of tolerance: the role of thymic lymphocytes.
Gershon, R. K., & Kondo, K. (1970) · PubMed Central · Cited by 917
Powrie, F., Carlino, J., Leach, M. W., Mauze, S., & Coffman, R. L. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2669 · Cited by 894
Allan, S. E., Crome, S. Q., Crellin, N. K., Passerini, L., Steiner, T. S., Bacchetta, R., Roncarolo, M. G., & Levings, M. K. (2007) · International Immunology · doi:10.1093/intimm/dxm014 · Cited by 872 · cited 1×
“fact, the majority of the defining markers – CD25 [39], FOXP3 [90, 91] and CTLA-4 [92] for”
BackgroundDefective Suppressor Function in CD4+CD25+ T-Cells From Patients With Type 1 Diabetes
Lindley, S., Dayan, C. M., Bishop, A., Roep, B. O., Peakman, M., & Tree, T. I. M. (2005) · Diabetes · doi:10.2337/diabetes.54.1.92 · Cited by 861
Induction and mechanism of action of transforming growth factor‐β‐secreting Th3 regulatory cells
Weiner, H. L. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820117.x · Cited by 846
Roncarolo, M. G., Bacchetta, R., Bordignon, C., Narula, S., & Levings, M. K. (2001) · Immunological Reviews · doi:10.1034/j.1600-065x.2001.1820105.x · Cited by 814
Mechanisms of impaired regulation by CD4+CD25+FOXP3+ regulatory T cells in human autoimmune diseases
Buckner, J. H. (2010) · Nature Reviews Immunology · doi:10.1038/nri2889 · Cited by 789
Gavin, M. A., Torgerson, T. R., Houston, E., deRoos, P., Ho, W. Y., Stray-Pedersen, A., Ocheltree, E. L., Greenberg, P. D., Ochs, H. D., & Rudensky, A. Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509484103 · Cited by 780
Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice
Tang, Q., Adams, J. Y., Tooley, A. J., Bi, M., Fife, B. T., Serra, P., Santamaria, P., Locksley, R. M., Krummel, M. F., & Bluestone, J. A. (2006) · Nature Immunology · doi:10.1038/ni1289 · Cited by 774
IL-10 Is Required for Regulatory T Cells to Mediate Tolerance to Alloantigens In Vivo
Hara, M., Kingsley, C. I., Niimi, M., Read, S., Turvey, S. E., Bushell, A. R., Morris, P. J., Powrie, F., & Wood, K. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3789 · Cited by 766
Gobert, M., Treilleux, I., Bendriss-Vermare, N., Bachelot, T., Goddard-Leon, S., Arfi, V., Biota, C., Doffin, A. C., Durand, I., Olive, D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2360 · Cited by 758
Onishi, Y., Fehervari, Z., Yamaguchi, T., & Sakaguchi, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711106105 · Cited by 716
Viguier, M., Lemaître, F., Verola, O., Cho, M.-S., Gorochov, G., Dubertret, L., Bachelez, H., Kourilsky, P., & Ferradini, L. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.2.1444 · Cited by 686
Peripheral and Intestinal Regulatory CD4+CD25high T Cells in Inflammatory Bowel Disease
Maul, J., Loddenkemper, C., Mundt, P., Berg, E., Giese, T., Stallmach, A., Zeitz, M., & Duchmann, R. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.043 · Cited by 651
Human CD4+CD25+ cells: a naturally occurring population of regulatory T cells
Ng, W. F., Duggan, P. J., Ponchel, F., Matarese, G., Lombardi, G., Edwards, A. D., Isaacs, J. D., & Lechler, R. I. (2001) · Blood · doi:10.1182/blood.v98.9.2736 · Cited by 609
Valencia, X., Yarboro, C., Illei, G., & Lipsky, P. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2579 · Cited by 594
Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level
Roncador, G., Brown, P. J., Maestre, L., Hue, S., Martínez-Torrecuadrada, J. L., Ling, K.-L., Pratap, S., Toms, C., Fox, B. C., Cerundolo, V., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200526189 · Cited by 592
Sugiyama, H., Gyulai, R., Toichi, E., Garaczi, E., Shimada, S., Stevens, S. R., McCormick, T. S., & Cooper, K. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.1.164 · Cited by 570
Two Functional Subsets of FOXP3+ Regulatory T Cells in Human Thymus and Periphery
Ito, T., Hanabuchi, S., Wang, Y.-H., Park, W. R., Arima, K., Bover, L., Qin, F. X.-F., Gilliet, M., & Liu, Y.-J. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.018 · Cited by 539
Huang, S., Apasov, S., Koshiba, M., & Sitkovsky, M. (1997) · Blood · doi:10.1182/blood.v90.4.1600 · Cited by 531
van Amelsfort, J. M. R., Jacobs, K. M. G., Bijlsma, J. W. J., Lafeber, F. P. J. G., & Taams, L. S. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20499 · Cited by 531
Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo
Tadokoro, C. E., Shakhar, G., Shen, S., Ding, Y., Lino, A. C., Maraver, A., Lafaille, J. J., & Dustin, M. L. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050783 · Cited by 527
The plasticity and stability of regulatory T cells
Sakaguchi, S., Vignali, D. A. A., Rudensky, A. Y., Niec, R. E., & Waldmann, H. (2013) · Nature Reviews Immunology · doi:10.1038/nri3464 · Cited by 525
T cells that cannot respond to TGF-β escape control by CD4+CD25+ regulatory T cells
Fahlén, L., Read, S., Gorelik, L., Hurst, S. D., Coffman, R. L., Flavell, R. A., & Powrie, F. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20040685 · Cited by 518
Zarek, P. E., Huang, C.-T., Lutz, E. R., Kowalski, J., Horton, M. R., Linden, J., Drake, C. G., & Powell, J. D. (2008) · Blood · doi:10.1182/blood-2007-03-081646 · Cited by 515
Nie, H., Zheng, Y., Li, R., Guo, T. B., He, D., Fang, L., Liu, X., Xiao, L., Chen, X., Wan, B., et al. (2013) · Nature Medicine · doi:10.1038/nm.3085 · Cited by 515
Defective regulatory and effector T cell functions in patients with FOXP3 mutations
Bacchetta, R. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25112 · Cited by 511
Activated CD4+CD25+ T cells selectively kill B lymphocytes
Zhao, D.-M., Thornton, A. M., DiPaolo, R. J., & Shevach, E. M. (2006) · Blood · doi:10.1182/blood-2005-11-4502 · Cited by 506
Beyer, M., Kochanek, M., Darabi, K., Popov, A., Jensen, M., Endl, E., Knolle, P. A., Thomas, R. K., von Bergwelt-Baildon, M., Debey, S., et al. (2005) · Blood · doi:10.1182/blood-2005-02-0642 · Cited by 492
CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis
Fletcher, J. M., Lonergan, R., Costelloe, L., Kinsella, K., Moran, B., O'Farrelly, C., Tubridy, N., & Mills, K. H. G. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901881 · Cited by 476
Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus
Miyara, M., Amoura, Z., Parizot, C., Badoual, C., Dorgham, K., Trad, S., Nochy, D., Debré, P., Piette, J.-C., & Gorochov, G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.12.8392 · Cited by 456
Haas, J., Hug, A., Viehöver, A., Fritzsching, B., Falk, C. S., Filser, A., Vetter, T., Milkova, L., Korporal, M., Fritz, B., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200526065 · Cited by 449
Regulatory T Cells Are Expanded in Blood and Disease Sites in Patients with Tuberculosis
Guyot-Revol, V., Innes, J. A., Hackforth, S., Hinks, T., & Lalvani, A. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200508-1294oc · Cited by 444
Jorn Bovenschen, H., van de Kerkhof, P. C., van Erp, P. E., Woestenenk, R., Joosten, I., & Koenen, H. J. P. M. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.139 · Cited by 415
Quantification of regulatory T cells in patients with systemic lupus erythematosus
Crispin, J. C., Martı́nez, A., & Alcocer-Varela, J. (2003) · Journal of Autoimmunity · doi:10.1016/s0896-8411(03)00121-5 · Cited by 408
Impairment of CD4+CD25+ regulatory T-cells in autoimmune liver disease
Longhi, M. S., Ma, Y., Bogdanos, D. P., Cheeseman, P., Mieli-Vergani, G., & Vergani, D. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.03.008 · Cited by 405
Self-citationBoettler, T., Spangenberg, H. C., Neumann-Haefelin, C., Panther, E., Urbani, S., Ferrari, C., Blum, H. E., von Weizsäcker, F., & Thimme, R. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7860-7867.2005 · Cited by 404
Functional Defects and the Influence of Age on the Frequency of CD4+CD25+ T-Cells in Type 1 Diabetes
Brusko, T. M., Wasserfall, C. H., Clare-Salzler, M. J., Schatz, D. A., & Atkinson, M. A. (2005) · Diabetes · doi:10.2337/diabetes.54.5.1407 · Cited by 398
Eastaff-Leung, N., Mabarrack, N., Barbour, A., Cummins, A., & Barry, S. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9345-1 · Cited by 392
A2A Adenosine Receptor Induction Inhibits IFN-γ Production in Murine CD4+ T Cells
Lappas, C. M., Rieger, J. M., & Linden, J. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.1073 · Cited by 385
Cosmi, L., Liotta, F., Lazzeri, E., Francalanci, M., Angeli, R., Mazzinghi, B., Santarlasci, V., Manetti, R., Vanini, V., Romagnani, P., et al. (2003) · Blood · doi:10.1182/blood-2003-04-1320 · Cited by 383
Human regulatory T cells: role in autoimmune disease and therapeutic opportunities
Brusko, T. M., Putnam, A. L., & Bluestone, J. A. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00637.x · Cited by 374
Decreased FOXP3 levels in multiple sclerosis patients
Huan, J., Culbertson, N., Spencer, L., Bartholomew, R., Burrows, G. G., Chou, Y. K., Bourdette, D., Ziegler, S. F., Offner, H., & Vandenbark, A. A. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20522 · Cited by 369
Sugimoto, K., Ikeda, F., Stadanlick, J., Nunes, F. A., Alter, H. J., & Chang, K.-M. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.026 · Cited by 369
Imbalance of regulatory T cells in human autoimmune diseases
Dejaco, C., Duftner, C., Grubeck‐Loebenstein, B., & Schirmer, M. (2006) · Immunology · doi:10.1111/j.1365-2567.2005.02317.x · Cited by 368
Walther, M., Tongren, J. E., Andrews, L., Korbel, D., King, E., Fletcher, H., Andersen, R. F., Bejon, P., Thompson, F., Dunachie, S. J., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.08.006 · Cited by 366
Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia
Ruprecht, C. R., Gattorno, M., Ferlito, F., Gregorio, A., Martini, A., Lanzavecchia, A., & Sallusto, F. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050085 · Cited by 361
Venken, K., Hellings, N., Thewissen, M., Somers, V., Hensen, K., Rummens, J., Medaer, R., Hupperts, R., & Stinissen, P. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02690.x · Cited by 360
Cao, D., Vollenhoven, R. V., Klareskog, L., Trollmo, C., & Malmström, V. (2004) · Arthritis Res Ther · doi:10.1186/ar1192 · Cited by 359
Selmi, C., Bowlus, C. L., Gershwin, M. E., & Coppel, R. L. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61965-4 · Cited by 334
Functional Study of CD4+CD25+ Regulatory T Cells in Health and Autoimmune Hepatitis
Longhi, M. S., Hussain, M. J., Mitry, R. R., Arora, S. K., Mieli-Vergani, G., Vergani, D., & Ma, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4484 · Cited by 323
Self-citationMöttönen, M., Heikkinen, J., Mustonen, L., Isomäki, P., Luukkainen, R., & Lassila, O. (2005) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2005.02754.x · Cited by 320
Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis
Flores-Borja, F., Jury, E. C., Mauri, C., & Ehrenstein, M. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806855105 · Cited by 312
Liver‐targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis†
Lan, R. Y., Cheng, C., Lian, Z., Tsuneyama, K., Yang, G., Moritoki, Y., Chuang, Y., Nakamura, T., Saito, S., Shimoda, S., et al. (2006) · Hepatology · doi:10.1002/hep.21123 · Cited by 305
Galectin-9 Induces Apoptosis Through the Calcium-Calpain-Caspase-1 Pathway
Kashio, Y., Nakamura, K., Abedin, M. J., Seki, M., Nishi, N., Yoshida, N., Nakamura, T., & Hirashima, M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3631 · Cited by 304
Schneider, A., Rieck, M., Sanda, S., Pihoker, C., Greenbaum, C., & Buckner, J. H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7350 · Cited by 301
FOXP3 Expression and Overall Survival in Breast Cancer
Merlo, A., Casalini, P., Carcangiu, M. L., Malventano, C., Triulzi, T., Mènard, S., Tagliabue, E., & Balsari, A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.9036 · Cited by 301
Hall, B. M., Pearce, N. W., Gurley, K. E., & Dorsch, S. E. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.1.141 · Cited by 298
Kessel, A., Haj, T., Peri, R., Snir, A., Melamed, D., Sabo, E., & Toubi, E. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.11.018 · Cited by 295
Hartigan-O'Connor, D. J., Poon, C., Sinclair, E., & McCune, J. M. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2006.10.008 · Cited by 289
Decreased CD4+CD25+ T Cells in Peripheral Blood of Patients with Systemic Lupus Erythematosus
Liu, M. ‐., Wang, C. ‐., Fung, L. ‐., & Wu, C. ‐. (2004) · Scandinavian Journal of Immunology · doi:10.1111/j.0300-9475.2004.01370.x · Cited by 282
Venken, K., Hellings, N., Broekmans, T., Hensen, K., Rummens, J.-L., & Stinissen, P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.6411 · Cited by 259
Ferraro, A., Socci, C., Stabilini, A., Valle, A., Monti, P., Piemonti, L., Nano, R., Olek, S., Maffi, P., Scavini, M., et al. (2011) · Diabetes · doi:10.2337/db11-0090 · Cited by 250
Regulatory T cells in patients with systemic lupus erythematosus
Alvarado-Sánchez, B., Hernández-Castro, B., Portales-Pérez, D., Baranda, L., Layseca-Espinosa, E., Abud-Mendoza, C., Cubillas-Tejeda, A. C., & González-Amaro, R. (2006) · Journal of Autoimmunity · doi:10.1016/j.jaut.2006.06.005 · Cited by 246
Effect of CD4+CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis
Longhi, M. S., Ma, Y., Mitry, R. R., Bogdanos, D. P., Heneghan, M., Cheeseman, P., Mieli-Vergani, G., & Vergani, D. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2005.05.001 · Cited by 237
Self-citationLawson, C. A., Brown, A. K., Bejarano, V., Douglas, S. H., Burgoyne, C. H., Greenstein, A. S., Boylston, A. W., Emery, P., Ponchel, F., & Isaacs, J. D. (2006) · Rheumatology · doi:10.1093/rheumatology/kel089 · Cited by 234
Oo, Y. H., Weston, C. J., Lalor, P. F., Curbishley, S. M., Withers, D. R., Reynolds, G. M., Shetty, S., Harki, J., Shaw, J. C., Eksteen, B., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901216 · Cited by 232
Expression of CD39 by Human Peripheral Blood CD4+CD25+ T Cells Denotes a Regulatory Memory Phenotype
Dwyer, K. M., Hanidziar, D., Putheti, P., Hill, P. A., Pommey, S., McRae, J. L., Winterhalter, A., Doherty, G., Deaglio, S., Koulmanda, M., et al. (2010) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2010.03291.x · Cited by 216
CD4+CD25high regulatory T cells in human autoimmune diabetes
Putnam, A. L., Vendrame, F., Dotta, F., & Gottlieb, P. A. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2004.11.004 · Cited by 205
Ferri, S., Longhi, M. S., De Molo, C., Lalanne, C., Muratori, P., Granito, A., Hussain, M. J., Ma, Y., Lenzi, M., Mieli-Vergani, G., et al. (2010) · Hepatology · doi:10.1002/hep.23792 · Cited by 204
Self-citationCharacterization of FOXP3+CD4+ regulatory T cells in Crohn's disease
Saruta, M., Yu, Q. T., Fleshner, P. R., Mantel, P.-Y., Schmidt-Weber, C. B., Banham, A. H., & Papadakis, K. A. (2007) · Clinical Immunology · doi:10.1016/j.clim.2007.08.003 · Cited by 204
Regulatory T Cells in Human Autoimmune Thyroid Disease
Marazuela, M., García-López, M. A., Figueroa-Vega, N., de la Fuente, H., Alvarado-Sánchez, B., Monsiváis-Urenda, A., Sánchez-Madrid, F., & González-Amaro, R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2337 · Cited by 201
Feger, U., Luther, C., Poeschel, S., Melms, A., Tolosa, E., & Wiendl, H. (2007) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2006.03271.x · Cited by 199
Chowdary Venigalla, R. K., Tretter, T., Krienke, S., Max, R., Eckstein, V., Blank, N., Fiehn, C., Dick Ho, A., & Lorenz, H. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23556 · Cited by 196
IL-23/IL-17 immunity as a hallmark of Crohnʼs disease
Hölttä, V., Klemetti, P., Sipponen, T., Westerholm-Ormio, M., Kociubinski, G., Salo, H., Räsänen, L., Kolho, K.-L., Färkkilä, M., Savilahti, E., et al. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20475 · Cited by 196
FOXP3+ regulatory T cells in autoimmune hepatitis are fully functional and not reduced in frequency
Peiseler, M., Sebode, M., Franke, B., Wortmann, F., Schwinge, D., Quaas, A., Baron, U., Olek, S., Wiegard, C., Lohse, A. W., et al. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.02.029 · Cited by 190
Grant, C. R., Liberal, R., Holder, B. S., Cardone, J., Ma, Y., Robson, S. C., Mieli-Vergani, G., Vergani, D., & Longhi, M. S. (2014) · Hepatology · doi:10.1002/hep.26583 · Cited by 188
Self-citationRegulatory T Cells Depress Immune Responses to Protective Antigens in Active Tuberculosis
Hougardy, J.-M., Place, S., Hildebrand, M., Drowart, A., Debrie, A.-S., Locht, C., & Mascart, F. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200701-084oc · Cited by 187
Tran, D. Q., Andersson, J., Hardwick, D., Bebris, L., Illei, G. G., & Shevach, E. M. (2009) · Blood · doi:10.1182/blood-2009-01-199950 · Cited by 187
Venken, K., Hellings, N., Hensen, K., Rummens, J., Medaer, R., D'hooghe, M. B., Dubois, B., Raus, J., & Stinissen, P. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20852 · Cited by 185
Holmén, N., Lundgren, A., Lundin, S., Bergin, A.-M., Rudin, A., Sjövall, H., & Öhman, L. (2006) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200606000-00003 · Cited by 183
Moradi, B., Schnatzer, P., Hagmann, S., Rosshirt, N., Gotterbarm, T., Kretzer, J. P., Thomsen, M. N., Lorenz, H., Zeifang, F., & Tretter, T. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4545 · Cited by 174
Lee, J., Wang, L., Lin, Y., Yang, Y., Lin, D., & Chiang, B. (2006) · Immunology · doi:10.1111/j.1365-2567.2005.02306.x · Cited by 172
Lawson, J. M., Tremble, J., Dayan, C., Beyan, H., Leslie, R. D. G., Peakman, M., & Tree, T. I. M. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03810.x · Cited by 168
Kmieciak, M., Gowda, M., Graham, L., Godder, K., Bear, H. D., Marincola, F. M., & Manjili, M. H. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-89 · Cited by 167
Lyssuk, E. Y., Torgashina, A. V., Soloviev, S. K., Nassonov, E. L., & Bykovskaia, S. N. (2007) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-387-72005-0_12 · Cited by 167
CD49d provides access to “untouched” human Foxp3+ Treg free of contaminating effector cells
Kleinewietfeld, M., Starke, M., Mitri, D. D., Borsellino, G., Battistini, L., Rötzschke, O., & Falk, K. (2008) · Blood · doi:10.1182/blood-2008-04-150524 · Cited by 166
Multiple treg suppressive modules and their adaptability
Wing, J. B., & Sakaguchi, S. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00178 · Cited by 164
Rong, G., Zhou, Y., Xiong, Y., Zhou, L., Geng, H., Jiang, T., Zhu, Y., Lu, H., Zhang, S., Wang, P., et al. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2009.03898.x · Cited by 162
D’Arena, G., Laurenti, L., Minervini, M. M., Deaglio, S., Bonello, L., De Martino, L., De Padua, L., Savino, L., Tarnani, M., De Feo, V., et al. (2011) · Leukemia Research · doi:10.1016/j.leukres.2010.08.010 · Cited by 161
Baranwal, M., Putzki, N., Limmroth, V., Remus, R., Lindemann, M., Knop, D., Mueller, N., Hardt, C., Kreuzfelder, E., & Grosse‐Wilde, H. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.08.003 · Cited by 160
Torcia, M. G., Santarlasci, V., Cosmi, L., Clemente, A., Maggi, L., Mangano, V. D., Verra, F., Bancone, G., Nébié, I., Sirima, B. S., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709969105 · Cited by 157
Mao, C., Wang, S., Xiao, Y., Xu, J., Jiang, Q., Jin, M., Jiang, X., Guo, H., Ning, G., & Zhang, Y. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0904135 · Cited by 156
Impairment of Regulatory T-Cell Function in Autoimmune Thyroid Disease
Glick, A., Wodzinski, A., Fu, P., Levine, A. D., & Wald, D. N. (2013) · Thyroid · doi:10.1089/thy.2012.0514 · Cited by 149
Liberal, R., Grant, C. R., Holder, B. S., Ma, Y., Mieli‐Vergani, G., Vergani, D., & Longhi, M. S. (2012) · Hepatology · doi:10.1002/hep.25682 · Cited by 145
Self-citationVenken, K., Thewissen, M. M., Hellings, N., Somers, V. A., Hensen, K., Rummens, J., & Stinissen, P. (2007) · Journal of Immunological Methods · doi:10.1016/j.jim.2007.01.025 · Cited by 144
Lin, S. ‐., Chen, K. ‐., Lin, C., Kuo, C. ‐., Ling, Q., & Chan, C. ‐. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01882.x · Cited by 142
Putheti, P., Pettersson, Å., Söderström, M. B., Link, H., & Huang, Y.-M. (2004) · Journal of Clinical Immunology · doi:10.1023/b:joci.0000019780.93817.82 · Cited by 140
Bohling, S. D., & Allison, K. H. (2008) · Modern Pathology · doi:10.1038/modpathol.2008.160 · Cited by 139
Sebode, M., Peiseler, M., Franke, B., Schwinge, D., Schoknecht, T., Wortmann, F., Quaas, A., Petersen, B., Ellinghaus, E., Baron, U., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.027 · Cited by 137
Todryk, S. M., Bejon, P., Mwangi, T., Plebanski, M., Urban, B. C., Marsh, K., Hill, A. V. S., & Flanagan, K. L. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002027 · Cited by 134
Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells
Wang, F., Wan, L., Zhang, C.-C., Zheng, X., Li, J., & Chen, Z. K. (2008) · Immunobiology · doi:10.1016/j.imbio.2008.10.007 · Cited by 127
Cutting Edge: Human Latency-Associated Peptide+ T Cells: A Novel Regulatory T Cell Subset
Gandhi, R., Farez, M., Wang, Y., Kozoriz, D., Quintana, F. J., & Weiner, H. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903329 · Cited by 124
Characterization of regulatory T cells in patients with B-cell chronic lymphocytic leukemia
Giannopoulos, K. (1994) · Oncology Reports · doi:10.3892/or_00000059 · Cited by 124
Longhi, M. S., Meda, F., Wang, P., Samyn, M., Mieli‐Vergani, G., Vergani, D., & Ma, Y. (2008) · Hepatology · doi:10.1002/hep.22071 · Cited by 124
Self-citationFuruhashi, T., Saito, C., Torii, K., Nishida, E., Yamazaki, S., & Morita, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054895 · Cited by 109
Decrease of regulatory T cells in patients with systemic lupus erythematosus
Mellor‐Pita, S., Citores, M. J., Castejon, R., Tutor‐Ureta, P., Yebra-Bango, M., Andreu, J. L., & Vargas, J. A. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.044974 · Cited by 109
Li, Z., Arijs, I., Hertogh, G. D., Vermeire, S., Noman, M., Bullens, D. M. A., Coorevits, L., Sagaert, X., Schuit, F. C., Rutgeerts, P., et al. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21229 · Cited by 103
TIM-3 Does Not Act as a Receptor for Galectin-9
Leitner, J. M., Rieger, A., Pickl, W. F., Zlabinger, G. J., Grabmeier‐Pfistershammer, K., & Steinberger, P. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003253 · Cited by 101
Next-generation insights into regulatory T cells: expression profiling and FoxP3 occupancy in Human
Birzele, F., Fauti, T., Stahl, H. F., Lenter, M., Simon, E., Knebel, D., Weith, A., Hildebrandt, T., & Mennerich, D. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr444 · Cited by 100
Expression of CD4+ forkhead box P3 (FOXP3)+ regulatory T cells in inflammatory bowel disease
Wang, Y., Xue Ping, L. I. U., Zhao, Z. B., Chen, J. H., & Cheng Gong, Y. U. (2011) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2011.00505.x · Cited by 99
Regulatory T cells fail to suppress CD4+ T‐bet+ T cells in relapsing multiple sclerosis patients
Frisullo, G., Nociti, V., Iorio, R., Patanella, A. K., Caggiula, M., Marti, A., Sancricca, C., Angelucci, F., Massimiliano Mirabella, A., Tonali, P. A., et al. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02963.x · Cited by 96
Kawashiri, S., Kawakami, A., Okada, A., Koga, T., Tamai, M., Yamasaki, S., Nakamura, H., Origuchi, T., Ida, H., & Eguchi, K. (2011) · The Journal of Rheumatology · doi:10.3899/jrheum.110283 · Cited by 93
Longhi, M. S., Mitry, R. R., Samyn, M., Scalori, A., Hussain, M. J., Quaglia, A., Mieli‐Vergani, G., Ma, Y., & Vergani, D. (2009) · Hepatology · doi:10.1002/hep.22914 · Cited by 89
Self-citationFenoglio, D., Bernuzzi, F., Battaglia, F., Parodi, A., Kalli, F., Negrini, S., Palma, R. D., Invernizzi, P., & Filaci, G. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.05.004 · Cited by 85
Targeting IRF4 in autoimmune diseases
Xu, W., Pan, H., Ye, D., & Xu, Y. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2012.08.011 · Cited by 85
Phenotypical and functional alterations of CD8 regulatory T cells in primary biliary cirrhosis
Bernuzzi, F., Fenoglio, D., Battaglia, F., Fravega, M., Gershwin, M. E., Indiveri, F., Ansari, A. A., Podda, M., Invernizzi, P., & Filaci, G. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2010.06.004 · Cited by 84
Immunosuppressive Dendritic and Regulatory T Cells are Upregulated in Melanoma Patients
McCarter, M. D., Baumgartner, J. M., Escobar, G. A., Richter, D., Lewis, K. D., Robinson, W. A., Wilson, C. C., Palmer, B. E., & Gonzalez, R. C. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9488-3 · Cited by 75
The Pathogen Recognition Receptor NOD2 Regulates Human FOXP3+ T Cell Survival
Rahman, M. K., Midtling, E., Svingen, P. A., Xiong, Y., Bell, M. P., Tung, J., Smyrk, T., Egan, L., & Faubion, W. A. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901479 · Cited by 74
Regulatory T cells in Graves’ disease
Pan, D., Shin, Y., Gopalakrishnan, G., Hennessey, J. V., & DeGroot, L. J. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03544.x · Cited by 71
Yates, J., Whittington, A., Mitchell, P., Lechler, R. I., Lightstone, L., & Lombardi, G. (2008) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2008.03665.x · Cited by 67
Bossowski, A. T., Moniuszko, M., Dąbrowska, M., Sawicka, B., Rusak, M., Jeznach, M., Wójtowicz, J., Bodzenta‐Łukaszyk, A., & Bossowska, A. (2012) · Autoimmunity · doi:10.3109/08916934.2012.751981 · Cited by 63
Wergeland, I., Aßmus, J., & Dyrhol‐Riise, A. M. (2010) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2010.02496.x · Cited by 59
Longhi, M. S., Ma, Y., Grant, C. R., Samyn, M., Gordon, P., Mieli‐Vergani, G., & Vergani, D. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.12.003 · Cited by 51
Self-citationCorrell, A., Tuettenberg, A., Becker, C., & Jonuleit, H. (2010) · Experimental Dermatology · doi:10.1111/j.1600-0625.2009.01055.x · Cited by 45
Osnes, L., Nakken, B., Bodolay, E., & Szodoray, P. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.02.003 · Cited by 44
Sasaki, M., Ikeda, H., Sawada, S., Sato, Y., & Nakanuma, Y. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.044776 · Cited by 42
Regulatory T cells in autoimmune hepatitis
Longhi, M. S., Ma, Y., Mieli‐Vergani, G., & Vergani, D. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.05.022 · Cited by 38
Self-citationCD4+CD25+ but not CD4+Foxp3+ T cells as a regulatory subset in primary biliary cirrhosis
Wang, D., Zhang, H., Liang, J., Gu, Z., Zhou, Q., Fan, X., Hou, Y., & Sun, L. (2010) · Cellular and Molecular Immunology · doi:10.1038/cmi.2010.40 · Cited by 37
Guidi, L., Felice, C., Procoli, A., Bonanno, G., Martinelli, E., Marzo, M., Mocci, G., Pugliese, D., Andrisani, G., Danese, S., et al. (2013) · BioMed Research International · doi:10.1155/2013/286368 · Cited by 35
Function of regulatory T-cells improved by dexamethasone in Graves' disease
Hu, Y., Tian, W., Zhang, L., Liu, H., Yin, G., He, B., & Mao, X. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-0879 · Cited by 35
Ma, L., Zhao, P., Jiang, Z., Shan, Y., & Jiang, Y. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12189 · Cited by 34
Role of immune dysfunction in pathogenesis of type 1 diabetes mellitus in children
He, J., Xie, P.-S., Luo, D., Sun, C., Zhang, Y., & Liu, F.-X. (2014) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/s1995-7645(14)60144-9 · Cited by 33
Enhanced killing activity of regulatory T cells ameliorates inflammation and autoimmunity
Askenasy, N. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.04.005 · Cited by 32
Critical co-stimulatory pathways in the stability of Foxp3+ Treg cell homeostasis in Type I Diabetes
Kornete, M., & Piccirillo, C. A. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.08.007 · Cited by 25
Schneider, A., & Buckner, J. H. (2011) · Methods in molecular biology · doi:10.1007/978-1-61737-979-6_15 · Cited by 18
Sebode, M., Peiseler, M., Weiler‐Normann, C., Schramm, C., Lohse, A. W., & Herkel, J. (2014) · Hepatology · doi:10.1002/hep.27301 · Cited by 6
Grant, C. R., Liberal, R., Ma, Y., Robson, S. C., Mieli‐Vergani, G., Vergani, D., & Longhi, M. S. (2014) · Hepatology · doi:10.1002/hep.27309 · Cited by 3
Self-citationTsuchihashi (2000) · doi:10.1002/1521-4141(200006)30:6
Cited by
Human autoimmune diseases: a comprehensive update
Wang, L., Wang, F., & Gershwin, M. E. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12395 · Cited by 1,168
Regulatory T Cells and Human Disease
Sakaguchi, S., Mikami, N., Wing, J. B., Tanaka, A., Ichiyama, K., & Ohkura, N. (2020) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042718-041717 · Cited by 1,120
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
Wing, J. B., Tanaka, A., & Sakaguchi, S. (2019) · Immunity · doi:10.1016/j.immuni.2019.01.020 · Cited by 726
Peptide and protein nanoparticle conjugates: versatile platforms for biomedical applications
Spicer, C. D., Jumeaux, C., Gupta, B., & Stevens, M. M. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00877e · Cited by 497
Therapeutic Potential of Targeting the Th17/Treg Axis in Autoimmune Disorders.
Fasching, P., Stradner, M., Graninger, W., Dejaco, C., & Fessler, J. (2017) · Molecules · doi:10.3390/molecules22010134 · Cited by 254
Metadata
- Authors
- Grant, C. R., Liberal, R., Mieli-Vergani, G., Vergani, D., & Longhi, M. S.
- Venue
- Autoimmunity Reviews
- Publisher
- Elsevier BV
- Published
- 2015-02
- Volume
- 14
- Issue
- 2
- Pages
- 105-116
- ISSN
- 1568-9972 (ISSN-L)
- OpenAlex
- W2087850939
- Cited by
- 292
- References
- 176
- FWCI
- 10.24
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.